The New England journal of medicine 2022 Sep 01
PD-1 Blockade in Mismatch Repair-Deficient Rectal Cancer.
Related Questions
New comment by Medical Oncologist at Mary Lanning Healthcare Morrison Cancer Center/University of Nebraska Medical Center Adjunct Faculty ( July 20, 2025)
Thank you, appreciate the query. As recurrence rates are extremely low for patients achieving pathological complete response (pCR) or major pathological response (MPR) after n...